INO-3112 vaccine
EORTC-1411
Phase 2 mab terminated
Quick answer
INO-3112 vaccine for Uterine Cervical Neoplasms is a Phase 2 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INOVIO PHARMACEUTICALS, INC.
- Indication
- Uterine Cervical Neoplasms
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated